Hologic(HOLX)
Search documents
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research· 2024-02-05 15:06
Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this medical device maker have returned -0.7% over the past month versus the Zacks S&P 500 composite's +4.6% change. The Zacks Medical - Instruments industry, to which Hologic belongs, has gained 3.9% over this period. Now the key question is: Where could the stock be headed in the near term?Although media ...
Hologic's (HOLX) Q1 Earnings Beat Estimates, Gross Margin Down
Zacks Investment Research· 2024-02-02 18:55
Hologic, Inc. (HOLX) reported adjusted earnings per share (EPS) of 98 cents in first-quarter fiscal 2024, down 8.4% year over year. The bottom line surpassed the Zacks Consensus Estimate by 3.2%.The adjustments include charges and benefits related to the amortization of acquired intangible assets, restructuring and integration/consolidation costs, product line discontinuation and many others.The company’s GAAP EPS were $1.03 in the quarter compared with the year-ago quarter’s EPS of 75 cents, up 37.3%.Reven ...
Hologic(HOLX) - 2024 Q1 - Earnings Call Transcript
2024-02-02 03:56
Hologic, Inc. (NASDAQ:HOLX) Q1 2024 Earnings Conference Call February 1, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Essex Mitchell - Chief Operating Officer Conference Call Participants Tejas Savant - Morgan Stanley Patrick Donnelly - Citi Jack Meehan - Nephron Research John Sourbeer - UBS Vijay Kumar - Evercore ISI Puneet Souda - Leerink Ryan Zimmerman - BTIG ...
Hologic (HOLX) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-02-01 23:31
Hologic (HOLX) reported $1.01 billion in revenue for the quarter ended December 2023, representing a year-over-year decline of 5.7%. EPS of $0.98 for the same period compares to $1.07 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $983.25 million, representing a surprise of +3.04%. The company delivered an EPS surprise of +3.16%, with the consensus EPS estimate being $0.95.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how ...
Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
Businesswire· 2024-02-01 22:35
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA), making it the first and only FDA-cleared digital cytology system that combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells. “Hologic is a leading innovat ...
Hologic Announces Financial Results for First Quarter of Fiscal 2024
Businesswire· 2024-02-01 21:01
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 30, 2023. “We delivered strong revenue and profitability to start fiscal 2024, exceeding the high-end of our guidance for both the top-line and the bottom-line. Adjusting for the four fewer selling days in the quarter, we estimate our organic growth rate ex. COVID-19 was in the high single digits, highlighting the bigger, faster, stronger Hologic we ...
Hologic(HOLX) - 2024 Q1 - Quarterly Report
2024-02-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HO ...
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Zacks Investment Research· 2024-01-23 17:40
Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or SONOVA HOLDING (SONVY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings est ...
3 Medical Instruments Stocks to Buy as Industry Trends Improve
Zacks Investment Research· 2024-01-23 16:16
The Medical Instruments industry witnessed a gradual transition toward remote healthcare and contactless services during the pandemic. With the crisis nearly over now, the key focus of medical device R&D is again shifting from COVID-related treatment options to point-of-care testing, heavy as well as minimally invasive implants, elective procedures, and so on and so forth.In fact, since the beginning of 2023, this industry has been witnessing massive adoption of artificial intelligence (AI) and the Internet ...
Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know
Zacks Investment Research· 2024-01-22 23:51
Hologic (HOLX) ended the recent trading session at $74.04, demonstrating a +0.71% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.22%. Elsewhere, the Dow gained 0.36%, while the tech-heavy Nasdaq added 0.32%.Heading into today, shares of the medical device maker had gained 3.49% over the past month, outpacing the Medical sector's gain of 2.3% and the S&P 500's gain of 1.61% in that time.The investment community will be paying close attention to the earnings per ...